Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Aastha Pal

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Hormone Molecular Biology and Clinical Investigation|February 5, 2021
COVID-19 and cardiovascular disease: a review of current knowledgeAastha Pal, Ashok Kumar Ahirwar, Apurva Sakarde, et al.
Nature|August 13, 2025
Expanding the cytokine receptor alphabet reprograms T cells into diverse statesYang Zhao, Masato Ogishi, Aastha Pal, et al.
Genome Medicine|August 15, 2025
SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomicsStefano Testa, Aastha Pal, Ajay Subramanian, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Hormone Molecular Biology and Clinical Investigation|February 5, 2021
COVID-19 and cardiovascular disease: a review of current knowledgeAastha Pal, Ashok Kumar Ahirwar, Apurva Sakarde, et al.
Nature|August 13, 2025
Expanding the cytokine receptor alphabet reprograms T cells into diverse statesYang Zhao, Masato Ogishi, Aastha Pal, et al.
Genome Medicine|August 15, 2025
SCAN-ACT: adoptive T cell therapy target discovery through single-cell transcriptomicsStefano Testa, Aastha Pal, Ajay Subramanian, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Immunity|November 22, 2025
IL-9 as a naturally orthogonal cytokine with optimal JAK/STAT signaling for engineered T cell therapyHua Jiang, Sam Limsuwannarot, Kayla R Kulhanek, et al.
Cancer Discovery|March 5, 2026
Neoadjuvant BO-112 and hypofractionated radiation therapy with or without nivolumab in soft tissue sarcoma: preclinical and phase 1 resultsJie Deng, Aastha Pal, Stefano Testa, et al.
Pageof 1